Craig-Hallum analyst Albert Lowe lowered the firm’s price target on Skye Bioscience (SKYE) to $14 from $18 and keeps a Buy rating on the ...

Craig-Hallum analyst Jeff Van Rhee maintained a Hold rating on Intellicheck Mobilisia (IDN – Research Report) today and set a price target of ...

Fintel reports that on March 20, 2025, Craig-Hallum initiated coverage of Veracyte (NasdaqGM:VCYT) with a Buy recommendation.

Analysts at Craig Hallum assumed coverage on shares of Veracyte (NASDAQ:VCYT – Get Free Report) in a note issued to investors ...

https://www.tipranks.com/news/the-fly/mongodb-price-target-lowered-to-240-from-275-at-scotiabank As previously reported, Craig-Hallum downgraded Akamai (AKAM) to Hold ...

https://www.tipranks.com/news/the-fly/smith-nephew-opens-door-to-break-up-in-response-to-activist-the-times-says As previously reported, Craig-Hallum analyst Albert ...

Detailed price information for Laird Superfood Inc (LSF-A) from The Globe and Mail including charting and trades.

Detailed price information for Astera Labs Inc (ALAB-Q) from The Globe and Mail including charting and trades.

Analysts expect the Philadelphia, Pennsylvania-based company to report quarterly earnings at $3.37 per share, down from $3.65 ...

Skye Bioscience (NASDAQ:SKYE – Get Free Report) had its price objective dropped by stock analysts at Craig Hallum from $18.00 to $14.00 in a research note issued on Friday,Benzinga reports. The ...

As of March 19, 2025, the average one-year price target for Veracyte is $46.31/share. The forecasts range from a low of $29.29 to a high of $56.70. The average price target represents an increase ...